FDA inspection
Novartis Pharmaceutical Manufacturing GmbH: FDA inspection ending Oct 10, 2025
FDA inspection 1327254 · Voluntary Action Indicated (VAI) · Langkampfen
Key facts
| Inspection ID | 1327254 |
|---|---|
| Firm | Novartis Pharmaceutical Manufacturing GmbH |
| FEI number | 3027031650 |
| Address | Biochemiestrase 10 |
| City | Langkampfen |
| Country | Austria |
| Fiscal year | 2026 |
| Inspection end date | Oct 10, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data